Pharmaceutical - Antibiotics and Infectious diseases, Anti-Arthritics/Rheumatics


Popular Filters

Briefs: Added use for Theravance's Vibativ; approval sought for ViiV dolutegravir; FDA accepts Pfizer sNDA for Xeljanz


USA-based Theravance (Nasdaq: THRX) says that the US Food and Drug Administration has approved the firm's…

Anti-Arthritics/RheumaticsAnti-viralsAntibiotics and Infectious diseasesBiotechnologydolutegravirNorth AmericaPfizerPharmaceuticalRegulationTheravanceVibativViiV HealthcareXeljanz

Back to top